Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Importance of smoking cessation for cardiovascular risk reduction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Day-to-day measurement of physical activity and risk of atrial fibrillation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Driving following defibrillator implantation: a nationwide register-linked survey study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. HIV infection is associated with type 2 diabetes mellitus

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Insulin resistance is associated with multiple chemical sensitivity in a danish population-based study—DanFunD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Lisa Pennells
  • Stephen Kaptoge
  • Angela Wood
  • Mike Sweeting
  • Xiaohui Zhao
  • Ian White
  • Stephen Burgess
  • Peter Willeit
  • Thomas Bolton
  • Karel G M Moons
  • Yvonne T van der Schouw
  • Randi Selmer
  • Kay-Tee Khaw
  • Vilmundur Gudnason
  • Gerd Assmann
  • Philippe Amouyel
  • Veikko Salomaa
  • Mika Kivimaki
  • Børge G Nordestgaard
  • Michael J Blaha
  • Lewis H Kuller
  • Hermann Brenner
  • Richard F Gillum
  • Christa Meisinger
  • Ian Ford
  • Matthew W Knuiman
  • Annika Rosengren
  • Debbie A Lawlor
  • Henry Völzke
  • Cyrus Cooper
  • Alejandro Marín Ibañez
  • Edoardo Casiglia
  • Jussi Kauhanen
  • Jackie A Cooper
  • Beatriz Rodriguez
  • Johan Sundström
  • Elizabeth Barrett-Connor
  • Rachel Dankner
  • Paul J Nietert
  • Karina W Davidson
  • Robert B Wallace
  • Dan G Blazer
  • Cecilia Björkelund
  • Chiara Donfrancesco
  • Harlan M Krumholz
  • Aulikki Nissinen
  • Barry R Davis
  • Sean Coady
  • Peter H Whincup
  • Torben Jørgensen
  • Emerging Risk Factors Collaboration
  • Anne Tybjærg-Hansen (Medlem af forfattergruppering)
Vis graf over relationer

Aims: There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied.

Methods and results: Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from 22 countries, we compared the Framingham risk score (FRS), Systematic COronary Risk Evaluation (SCORE), pooled cohort equations (PCE), and Reynolds risk score (RRS). We calculated measures of risk discrimination and calibration, and modelled clinical implications of initiating statin therapy in people judged to be at 'high' 10 year CVD risk. Original risk algorithms were recalibrated using the risk factor profile and CVD incidence of target populations. The four algorithms had similar risk discrimination. Before recalibration, FRS, SCORE, and PCE over-predicted CVD risk on average by 10%, 52%, and 41%, respectively, whereas RRS under-predicted by 10%. Original versions of algorithms classified 29-39% of individuals aged ≥40 years as high risk. By contrast, recalibration reduced this proportion to 22-24% for every algorithm. We estimated that to prevent one CVD event, it would be necessary to initiate statin therapy in 44-51 such individuals using original algorithms, in contrast to 37-39 individuals with recalibrated algorithms.

Conclusion: Before recalibration, the clinical performance of four widely used CVD risk algorithms varied substantially. By contrast, simple recalibration nearly equalized their performance and improved modelled targeting of preventive action to clinical need.

OriginalsprogEngelsk
TidsskriftEuropean Heart Journal
Vol/bind40
Udgave nummer7
Sider (fra-til)621-631
Antal sider11
ISSN0195-668X
DOI
StatusUdgivet - 14 feb. 2019

ID: 56448179